The Extracellular Matrix in Pancreatic Cancer: Description of a Complex Network and Promising Therapeutic Options.

cancer-associated fibroblasts extracellular matrix matrix remodeling solid stress stiffness stroma

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
03 Sep 2021
Historique:
received: 04 08 2021
revised: 30 08 2021
accepted: 31 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 11 9 2021
Statut: epublish

Résumé

The stroma is a relevant player in driving and supporting the progression of pancreatic ductal adenocarcinoma (PDAC), and a large body of evidence highlights its role in hindering the efficacy of current therapies. In fact, the dense extracellular matrix (ECM) characterizing this tumor acts as a natural physical barrier, impairing drug penetration. Consequently, all of the approaches combining stroma-targeting and anticancer therapy constitute an appealing option for improving drug penetration. Several strategies have been adopted in order to target the PDAC stroma, such as the depletion of ECM components and the targeting of cancer-associated fibroblasts (CAFs), which are responsible for the increased matrix deposition in cancer. Additionally, the leaky and collapsing blood vessels characterizing the tumor might be normalized, thus restoring blood perfusion and allowing drug penetration. Even though many stroma-targeting strategies have reported disappointing results in clinical trials, the ECM offers a wide range of potential therapeutic targets that are now being investigated. The dense ECM might be bypassed by implementing nanoparticle-based systems or by using mesenchymal stem cells as drug carriers. The present review aims to provide an overview of the principal mechanisms involved in the ECM remodeling and of new promising therapeutic strategies for PDAC.

Identifiants

pubmed: 34503252
pii: cancers13174442
doi: 10.3390/cancers13174442
pmc: PMC8430646
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Subventions

Organisme : AIRC 5 x 1000
ID : 22737

Références

Cytotherapy. 2010 Sep;12(5):615-25
pubmed: 20230221
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2017 May;9(3):
pubmed: 28185434
Stem Cells. 2012 Jul;30(7):1575-8
pubmed: 22553154
Gastroenterology. 2016 Jun;150(7):1545-1557.e2
pubmed: 27072672
Front Oncol. 2014 Dec 19;4:361
pubmed: 25566500
J Biomech Eng. 2017 Jun 1;139(6):
pubmed: 28388715
Front Physiol. 2014 Mar 05;5:75
pubmed: 24634660
Theranostics. 2020 Mar 15;10(10):4614-4626
pubmed: 32292518
Semin Cancer Biol. 2020 May;62:9-19
pubmed: 31319162
Br J Cancer. 2020 Feb;122(4):498-505
pubmed: 31857726
BMB Rep. 2010 Jan;43(1):52-6
pubmed: 20132736
Clin Transl Med. 2019 Apr 1;8(1):10
pubmed: 30931508
Drug Resist Updat. 2017 Mar;31:43-51
pubmed: 28867243
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4822-7
pubmed: 19264968
Dev Cell. 2019 May 6;49(3):332-346
pubmed: 31063753
HPB (Oxford). 2018 Jul;20(7):597-604
pubmed: 29339034
Ann Gastroenterol Surg. 2019 Jan 04;3(2):130-137
pubmed: 30923782
Eur J Radiol. 2014 Mar;83(3):415-9
pubmed: 23726121
Clin Cancer Res. 2014 Jul 15;20(14):3637-43
pubmed: 25028505
Gastroenterology. 2013 Nov;145(5):1121-32
pubmed: 23891972
Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15101-8
pubmed: 22932871
Mol Cell Proteomics. 2012 Apr;11(4):M111.014647
pubmed: 22159717
Cancer Cell. 2014 Jun 16;25(6):719-34
pubmed: 24856586
Cell Death Dis. 2021 Mar 29;12(4):334
pubmed: 33782384
Stem Cells. 2006 May;24(5):1254-64
pubmed: 16410389
Sci Rep. 2017 Jul 28;7(1):6838
pubmed: 28754894
Acta Biomater. 2018 Feb;67:331-340
pubmed: 29191507
Int J Oncol. 2020 Feb;56(2):596-605
pubmed: 31894273
Front Mol Biosci. 2020 Jan 31;6:160
pubmed: 32118030
J Cell Physiol. 2012 Feb;227(2):534-49
pubmed: 21437907
JCI Insight. 2019 Jul 23;5:
pubmed: 31335328
Discov Med. 2011 Feb;11(57):160-70
pubmed: 21356171
Cell Death Dis. 2020 May 11;11(5):349
pubmed: 32393744
Mol Pharm. 2014 Jul 7;11(7):2390-9
pubmed: 24827725
Cancer Sci. 2006 Feb;97(2):91-8
pubmed: 16441418
Cell Mol Life Sci. 2021 May;78(9):4201-4219
pubmed: 33582842
Ann Biomed Eng. 2013 Jan;41(1):68-77
pubmed: 22855118
J Exp Clin Cancer Res. 2017 Sep 29;36(1):135
pubmed: 28962658
Cancer Res. 2015 Nov 15;75(22):4681-7
pubmed: 26471358
Front Oncol. 2018 Mar 12;8:55
pubmed: 29594037
Curr Opin Biotechnol. 2016 Aug;40:41-48
pubmed: 26938687
J Glaucoma. 2014 Oct-Nov;23(8 Suppl 1):S20-3
pubmed: 25275899
Biomaterials. 2016 Oct;103:12-21
pubmed: 27376555
Sci Rep. 2017 May 31;7(1):2506
pubmed: 28566691
Cancer Res. 2020 Apr 1;80(7):1461-1474
pubmed: 32029550
Cancer Treat Rev. 2020 Jun;86:102016
pubmed: 32247999
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20212-7
pubmed: 24277834
Biomaterials. 2020 Jul;246:119999
pubmed: 32247201
Sci Rep. 2017 Jan 10;7:40495
pubmed: 28071719
Science. 2009 Jun 12;324(5933):1457-61
pubmed: 19460966
Mol Pharm. 2014 Jul 7;11(7):2016-21
pubmed: 24754837
Science. 2020 Oct 30;370(6516):
pubmed: 33122355
Br J Cancer. 1997;75(4):566-71
pubmed: 9052412
Cancer Cell. 2010 Feb 17;17(2):135-47
pubmed: 20138012
Mol Med Rep. 2021 Jan;23(1):
pubmed: 33179081
Matrix Biol. 2019 May;78-79:165-179
pubmed: 29753676
Mol Cancer Ther. 2018 Jun;17(6):1147-1155
pubmed: 29735645
Nanoscale. 2018 Jan 18;10(3):881-906
pubmed: 29265147
Front Biosci (Landmark Ed). 2010 Jan 01;15:166-79
pubmed: 20036813
J Extracell Vesicles. 2017 Mar 7;6(1):1286095
pubmed: 28326170
Methods Mol Biol. 2008;449:27-44
pubmed: 18370081
Cancer Cell. 2014 Jun 16;25(6):735-47
pubmed: 24856585
Cancer Lett. 2017 Apr 10;391:38-49
pubmed: 28093284
Stem Cells. 2012 May;30(5):804-10
pubmed: 22415904
Annu Rev Biomed Eng. 2014 Jul 11;16:321-46
pubmed: 25014786
Physiol Rev. 2011 Jul;91(3):1071-121
pubmed: 21742796
Nat Med. 2013 Nov;19(11):1423-37
pubmed: 24202395
Oncol Lett. 2019 Mar;17(3):3055-3065
pubmed: 30867734
PLoS One. 2008 Jun 18;3(6):e2518
pubmed: 18560571
J Exp Med. 2017 Mar 6;214(3):579-596
pubmed: 28232471
ACS Nano. 2017 Sep 26;11(9):8668-8678
pubmed: 28806504
Onco Targets Ther. 2013 Dec 18;7:33-43
pubmed: 24379681
Clin Cancer Res. 2014 Dec 1;20(23):5937-5945
pubmed: 25278454
Oncogene. 2018 Nov;37(46):6041-6053
pubmed: 29993037
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Cancer Immunol Res. 2014 Feb;2(2):154-66
pubmed: 24778279
ACS Appl Mater Interfaces. 2021 Mar 24;13(11):12824-12835
pubmed: 33689289
Oncogenesis. 2017 Jul 3;6(7):e352
pubmed: 28671675
N Engl J Med. 1986 Dec 25;315(26):1650-9
pubmed: 3537791
Curr Opin Cell Biol. 2019 Feb;56:71-79
pubmed: 30308331
Biology (Basel). 2020 Apr 18;9(4):
pubmed: 32325664
Nat Med. 2016 May 5;22(5):462-3
pubmed: 27149218
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Int J Pharm. 2015 Oct 15;494(1):249-57
pubmed: 26216413
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Cancer Discov. 2019 Aug;9(8):1102-1123
pubmed: 31197017
J Burn Care Res. 2010 Jan-Feb;31(1):158-75
pubmed: 20061852
Am J Pathol. 2010 Nov;177(5):2585-96
pubmed: 20934972
PLoS One. 2011;6(12):e28321
pubmed: 22205945
Matrix Biol. 2002 Mar;21(2):115-28
pubmed: 11852228
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Gastroenterology. 2011 Oct;141(4):1486-97, 1497.e1-14
pubmed: 21704588
JCI Insight. 2018 Sep 20;3(18):
pubmed: 30232274
Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):299-310
pubmed: 25301203
Nat Med. 2016 May;22(5):497-505
pubmed: 27089513
Leukemia. 2007 Mar;21(3):568-70
pubmed: 17252011
Nature. 2016 Mar 3;531(7592):47-52
pubmed: 26909576
PLoS One. 2013 Aug 22;8(8):e71978
pubmed: 23991015
Front Cell Dev Biol. 2020 Jul 15;8:630
pubmed: 32760726
J Cell Mol Med. 2019 Jun;23(6):3878-3887
pubmed: 30941918
Biomaterials. 2020 Feb;232:119745
pubmed: 31918228
Aging (Albany NY). 2019 Jun 10;11(11):3679-3703
pubmed: 31182680
Proc SPIE Int Soc Opt Eng. 2016 Apr 17;9836:
pubmed: 27313332
Oncol Lett. 2018 Jul;16(1):199-210
pubmed: 29928402
Stem Cells. 2002;20(6):530-41
pubmed: 12456961
Int J Immunopathol Pharmacol. 2013 Jan-Mar;26(1 Suppl):33-41
pubmed: 24046947
Mol Ther. 2013 Aug;21(8):1611-20
pubmed: 23732988
J Clin Invest. 2006 Jul;116(7):1955-62
pubmed: 16794736
Cell Rep. 2019 May 14;27(7):2036-2049.e6
pubmed: 31091444
Am Fam Physician. 2014 Apr 15;89(8):626-32
pubmed: 24784121
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2013 Mar-Apr;5(2):111-29
pubmed: 23335558
Nat Commun. 2013;4:2516
pubmed: 24084631
Arch Surg. 1997 May;132(5):541-6
pubmed: 9161399
Nat Med. 2017 Jul;23(7):890-898
pubmed: 28604702
Cell Death Dis. 2019 Mar 8;10(3):230
pubmed: 30850586
Cancer Cell. 2018 Mar 12;33(3):463-479.e10
pubmed: 29455927
Mol Cell. 2017 Aug 3;67(3):512-527.e4
pubmed: 28757207
Int J Cancer. 2019 Mar 15;144(6):1401-1413
pubmed: 30152542
Cancers (Basel). 2021 Feb 27;13(5):
pubmed: 33673405
Mol Biol Cell. 2020 Aug 1;31(17):1823-1834
pubmed: 32730166
Clin Cancer Res. 2019 Apr 1;25(7):2136-2143
pubmed: 30352906
Sci Transl Med. 2018 Jan 3;10(422):
pubmed: 29298864
Cytotherapy. 2015 Dec;17(12):1687-95
pubmed: 26481416
Sci Rep. 2017 Nov 8;7(1):15008
pubmed: 29118431
Biomed Mater. 2017 Jul 04;12(4):045005
pubmed: 28396578
J Clin Oncol. 2019 May 1;37(13):1062-1069
pubmed: 30817250
Am J Obstet Gynecol. 2010 Nov;203(5):495.e9-495.e23
pubmed: 20692642
Stem Cells Dev. 2004 Dec;13(6):658-64
pubmed: 15684833
Neural Regen Res. 2021 Mar;16(3):405-413
pubmed: 32985458
Nat Rev Gastroenterol Hepatol. 2020 Aug;17(8):487-505
pubmed: 32393771
J Clin Invest. 2009 Nov;119(11):3356-72
pubmed: 19809158
Cancer Res. 2005 Jul 15;65(14):5991-5; discussion 5995
pubmed: 16024595
Cell Oncol (Dordr). 2013 Jul;36(4):277-88
pubmed: 23619944
Biochem Biophys Res Commun. 2010 Dec 17;403(3-4):380-4
pubmed: 21081113
Proc Natl Acad Sci U S A. 2019 May 28;116(22):11057-11062
pubmed: 31085647
J Biol Chem. 1997 Jul 4;272(27):17216-22
pubmed: 9202045
ACS Nano. 2019 Oct 22;13(10):11008-11021
pubmed: 31503443
Adv Drug Deliv Rev. 2018 Apr;129:37-53
pubmed: 29414674
Trends Pharmacol Sci. 2016 Jul;37(7):606-617
pubmed: 27157716
Exp Cell Res. 2010 May 1;316(8):1324-31
pubmed: 20211171
World J Gastroenterol. 2011 Jan 28;17(4):409-18
pubmed: 21274370
J Proteome Res. 2007 May;6(5):1782-91
pubmed: 17381149
Nat Nanotechnol. 2011 Oct 23;6(12):815-23
pubmed: 22020122
Proteomics. 2013 May;13(10-11):1624-36
pubmed: 23526769
World J Gastroenterol. 2016 Mar 7;22(9):2678-700
pubmed: 26973408
Nat Commun. 2017 Oct 13;8(1):924
pubmed: 29030636
Int J Oncol. 2007 Mar;30(3):593-603
pubmed: 17273760
Cancer Res. 2016 Dec 15;76(24):7181-7193
pubmed: 27754848
Nat Commun. 2017 Jan 19;8:14105
pubmed: 28102238
Nat Rev Gastroenterol Hepatol. 2019 May;16(5):282-295
pubmed: 30778141
Cancer Cell. 2012 Mar 20;21(3):418-29
pubmed: 22439937
Physiol Rev. 2021 Jan 1;101(1):147-176
pubmed: 32466724
Int J Oncol. 2012 May;40(5):1345-57
pubmed: 22246533
Anal Chem. 1997 Dec 1;69(23):4751-60
pubmed: 9406525
Cancer Sci. 2013 Feb;104(2):157-64
pubmed: 23121112
Theranostics. 2021 Jan 1;11(5):2182-2200
pubmed: 33500719
J Cell Sci. 1966 Sep;1(3):297-310
pubmed: 4291022
Cancer Res. 2013 Sep 15;73(18):5657-68
pubmed: 23903958
Clin Cancer Res. 2007 Sep 1;13(17):5020-7
pubmed: 17785552
Br J Cancer. 2001 Dec 14;85(12):1865-70
pubmed: 11747327
Matrix Biol. 2019 Jan;75-76:160-169
pubmed: 29106944
Nat Cell Biol. 2007 Jun;9(6):654-9
pubmed: 17486113
Nat Biotechnol. 2007 Jan;25(1):100-6
pubmed: 17206138
Cell Growth Differ. 1996 Mar;7(3):383-95
pubmed: 8838868
Neoplasia. 2005 Jun;7(6):623-9
pubmed: 16036113
Stem Cells. 2007 Feb;25(2):520-8
pubmed: 17053212
Trends Cancer. 2019 Nov;5(11):724-741
pubmed: 31735290
J Clin Invest. 2007 Jan;117(1):50-9
pubmed: 17200706
J Clin Oncol. 2018 Feb 1;36(4):359-366
pubmed: 29232172
J Orthop Translat. 2017 Apr 09;9:76-88
pubmed: 29662802
Integr Biol (Camb). 2016 Dec 5;8(12):1232-1245
pubmed: 27761545
Mol Cancer. 2009 Dec 21;8:125
pubmed: 20021699
Nat Rev Immunol. 2004 Aug;4(8):617-29
pubmed: 15286728
Front Cell Dev Biol. 2020 Nov 30;8:569377
pubmed: 33330449
Stem Cells Int. 2016;2016:6901286
pubmed: 27651799
Ann Biomed Eng. 2011 May;39(5):1379-89
pubmed: 21253819
Cells Tissues Organs. 2001;169(1):12-20
pubmed: 11340257
ACS Nano. 2015 Aug 25;9(8):7976-91
pubmed: 26242412
Nature. 2008 Sep 18;455(7211):406-10
pubmed: 18754008
J Surg Res. 2014 Dec;192(2):268-75
pubmed: 25086727
Nat Commun. 2020 Oct 9;11(1):5120
pubmed: 33037194
Nature. 2019 Apr;568(7752):410-414
pubmed: 30918400
Matrix Biol. 2009 Jul;28(6):336-46
pubmed: 19442729
Cancers (Basel). 2018 Sep 06;10(9):
pubmed: 30200666
J Mass Spectrom. 2015 Nov;50(11):1288-93
pubmed: 26505774
Nat Commun. 2016 Sep 07;7:12630
pubmed: 27600527
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188444
pubmed: 33031899
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
Annu Rev Chem Biomol Eng. 2011;2:281-98
pubmed: 22432620
Curr Opin Cell Biol. 2016 Dec;43:7-13
pubmed: 27371787
J Control Release. 2012 Jan 30;157(2):168-82
pubmed: 21839127
Front Cell Dev Biol. 2019 Nov 21;7:255
pubmed: 31824942
Biophys J. 2009 Sep 16;97(6):1569-77
pubmed: 19751661
Nat Commun. 2019 Aug 12;10(1):3637
pubmed: 31406163
Cancer Discov. 2018 Mar;8(3):304-319
pubmed: 29196464
Br J Cancer. 2019 Aug;121(4):293-302
pubmed: 31289350
Circulation. 2005 May 17;111(19):2509-17
pubmed: 15883213
J Pathol. 2013 Jan;229(2):157-67
pubmed: 23023641
J Cell Biol. 2017 Nov 6;216(11):3509-3520
pubmed: 28931556
Connect Tissue Res. 2015;56(5):403-13
pubmed: 26291767
BMB Rep. 2018 Mar;51(3):126-133
pubmed: 29366442
Pancreas. 2009 May;38(4):427-35
pubmed: 19188864
Ecancermedicalscience. 2018 Mar 28;12:822
pubmed: 29662535
PLoS One. 2017 Nov 30;12(11):e0188870
pubmed: 29190794
PLoS One. 2010 Dec 23;5(12):e15787
pubmed: 21203423
J Natl Cancer Inst. 2002 Aug 7;94(15):1134-42
pubmed: 12165638
J Clin Oncol. 2020 Sep 20;38(27):3185-3194
pubmed: 32706635
Curr Opin Immunol. 2020 May 10;64:80-87
pubmed: 32402828
Cell. 2014 Sep 25;159(1):80-93
pubmed: 25259922
Sci Rep. 2016 Feb 26;6:22179
pubmed: 26916665
Cancer Gene Ther. 2012 Sep;19(9):652-8
pubmed: 22767216
Clin Genet. 2012 Jul;82(1):1-11
pubmed: 22353005
J Cell Biol. 2003 Nov 24;163(4):871-8
pubmed: 14638862
Nat Cell Biol. 2008 May;10(5):619-24
pubmed: 18425114
Ann Surg. 2007 Apr;245(4):566-72
pubmed: 17414605
Pancreatology. 2016 Nov - Dec;16(6):1063-1068
pubmed: 27692969
Gastroenterology. 2019 May;156(7):2085-2096
pubmed: 30721663
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21677-82
pubmed: 21098274
Clin Cancer Res. 2019 Apr 1;25(7):2024-2026
pubmed: 30630829
Nat Rev Clin Oncol. 2010 Nov;7(11):653-64
pubmed: 20838415
Exp Cell Res. 2015 Nov 1;338(2):162-9
pubmed: 26410556
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Ann Biomed Eng. 2018 May;46(5):657-669
pubmed: 29470747
J Clin Oncol. 2003 Sep 1;21(17):3296-302
pubmed: 12947065
Cell Rep. 2017 Mar 7;18(10):2464-2479
pubmed: 28273460
Cell. 2018 Feb 8;172(4):643-644
pubmed: 29425485
Ann N Y Acad Sci. 1999 Jun 30;878:497-9
pubmed: 10415753
J Clin Oncol. 1997 Jun;15(6):2403-13
pubmed: 9196156
Matrix Biol. 2016 Jan;49:10-24
pubmed: 26163349
Phys Biol. 2011 Apr;8(2):026013
pubmed: 21441648
Sci Rep. 2016 Jul 04;6:27639
pubmed: 27375161
World J Gastroenterol. 2013 Jan 7;19(1):42-8
pubmed: 23326161
Mol Cancer Ther. 2010 Nov;9(11):3052-64
pubmed: 20978165
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17188-93
pubmed: 25404301
Cell Stem Cell. 2014 Apr 3;14(4):431-44
pubmed: 24702995
Front Oncol. 2017 Oct 09;7:242
pubmed: 29062810
Annu Rev Biomed Eng. 2010 Aug 15;12:87-117
pubmed: 20415588
PLoS One. 2013 Aug 05;8(8):e70395
pubmed: 23940570
Int J Mol Sci. 2020 Jul 31;21(15):
pubmed: 32752017
Cancer Biol Ther. 2006 Dec;5(12):1640-6
pubmed: 17106243
Int J Cancer. 2014 Aug 15;135(4):1002-6
pubmed: 24458568
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2210-2219
pubmed: 30659155
N Engl J Med. 2018 Dec 20;379(25):2395-2406
pubmed: 30575490
Gut. 2011 Jun;60(6):861-8
pubmed: 20966025
Mol Pharm. 2018 Jun 4;15(6):2069-2083
pubmed: 29767984
Cancer Cell. 2014 Jun 16;25(6):711-2
pubmed: 24937454
Gut. 2021 Feb 10;:
pubmed: 33568427
FEBS J. 2019 Aug;286(15):2883-2908
pubmed: 30724463
Stem Cell Res Ther. 2010 Mar 15;1(1):4
pubmed: 20504285
Gut. 2018 Mar;67(3):497-507
pubmed: 28077438
OMICS. 2020 Jun;24(6):314-339
pubmed: 32496970
Biomater Sci. 2019 Feb 26;7(3):843-855
pubmed: 30648168
Biophys J. 2016 May 10;110(9):2106-19
pubmed: 27166818
Int J Exp Pathol. 2018 Apr;99(2):58-76
pubmed: 29671911
Stem Cells Int. 2016;2016:3970942
pubmed: 27610137
Eur J Cancer. 2021 Mar;146:125-134
pubmed: 33607476
Clin Cancer Res. 2018 Mar 1;24(5):1190-1201
pubmed: 29269377
Cancers (Basel). 2020 Dec 15;12(12):
pubmed: 33333727
J Pathol. 2000 Oct;192(2):150-8
pubmed: 11004690
Annu Rev Biomed Eng. 2012;14:1-16
pubmed: 22524388
EMBO Mol Med. 2015 Jun 15;7(8):1063-76
pubmed: 26077591
Gut. 2017 Aug;66(8):1449-1462
pubmed: 27053631
Cancer Sci. 2020 Apr;111(4):1047-1057
pubmed: 32060987
N Engl J Med. 2013 Oct 31;369(18):1691-703
pubmed: 24131140
J Clin Oncol. 2015 Dec 20;33(36):4284-92
pubmed: 26527777
Sci Rep. 2020 Mar 25;10(1):5420
pubmed: 32214219
Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2426-31
pubmed: 21245339
Free Radic Biol Med. 2015 Feb;79:269-80
pubmed: 25532934
Clin Cancer Res. 2015 Aug 1;21(15):3561-8
pubmed: 25695692
Nat Biomed Eng. 2016;1:
pubmed: 28966873
Acta Biomater. 2013 Jan;9(1):4635-44
pubmed: 22902816
Curr Pharm Des. 2012;18(13):1821-45
pubmed: 22352750
Cancer Gene Ther. 2021 Sep;28(9):984-999
pubmed: 33712707
Nat Rev Urol. 2014 Dec;11(12):688-701
pubmed: 25403245
Clin Cancer Res. 2016 Jun 15;22(12):2848-54
pubmed: 26813359
Acc Chem Res. 2016 Sep 20;49(9):1731-40
pubmed: 27564418
PLoS One. 2014 Mar 11;9(3):e90353
pubmed: 24618589
Ann Surg. 2009 Nov;250(5):747-53
pubmed: 19826249
Mol Cancer. 2019 Jan 21;18(1):14
pubmed: 30665410
Ann Rheum Dis. 2015 Jul;74(7):1408-16
pubmed: 24567525
Nat Rev Cancer. 2017 Dec;17(12):738-750
pubmed: 29123246
Stem Cells Dev. 2009 Jun;18(5):683-92
pubmed: 19099374

Auteurs

Benedetta Ferrara (B)

Diabetes Research Institute (HSR-DRI), San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.

Cataldo Pignatelli (C)

Diabetes Research Institute (HSR-DRI), San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.

Mélissande Cossutta (M)

INSERM U955, Immunorégulation et Biothérapie, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, 94010 Créteil, France.
AP-HP, Centre d'Investigation Clinique Biothérapie, Groupe Hospitalo-Universitaire Chenevier Mondor, 94010 Créteil, France.

Antonio Citro (A)

Diabetes Research Institute (HSR-DRI), San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.

José Courty (J)

INSERM U955, Immunorégulation et Biothérapie, Institut Mondor de Recherche Biomédicale (IMRB), Université Paris-Est Créteil, 94010 Créteil, France.
AP-HP, Centre d'Investigation Clinique Biothérapie, Groupe Hospitalo-Universitaire Chenevier Mondor, 94010 Créteil, France.

Lorenzo Piemonti (L)

Diabetes Research Institute (HSR-DRI), San Raffaele Scientific Institute, via Olgettina 60, 20132 Milan, Italy.

Classifications MeSH